These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2193492)

  • 21. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.
    van den Brand MJ; Rensing BJ; Morel MA; Foley DP; de Valk V; Breeman A; Suryapranata H; Haalebos MM; Wijns W; Wellens F; Balcon R; Magee P; Ribeiro E; Buffolo E; Unger F; Serruys PW
    J Am Coll Cardiol; 2002 Feb; 39(4):559-64. PubMed ID: 11849851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease.
    Mulcahy D; Husain S; Zalos G; Rehman A; Andrews NP; Schenke WH; Geller NL; Quyyumi AA
    JAMA; 1997 Jan 22-29; 277(4):318-24. PubMed ID: 9002495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized comparison of the effects of gradual prolonged versus standard primary balloon inflation on early and late outcome. Results of a multicenter clinical trial. Perfusion Balloon Catheter Study Group.
    Ohman EM; Marquis JF; Ricci DR; Brown RI; Knudtson ML; Kereiakes DJ; Samaha JK; Margolis JR; Niederman AL; Dean LS
    Circulation; 1994 Mar; 89(3):1118-25. PubMed ID: 8124798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
    Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G
    Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ischemia: outcome with medical therapy versus revascularization.
    Miller TD; Christian TF; Taliercio CP; Zinsmeister AR; Orszulak TA; Schaff HV; Gibbons RJ
    Mayo Clin Proc; 1994 Jul; 69(7):626-31. PubMed ID: 8015324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and angiographic follow-up after coronary angioplasty in patients with two-vessel disease: influence of completeness and adequacy of revascularization on long-term outcome.
    Cavallini C; Risica G; Olivari Z; Marton F; Franceschini E; Giommi L
    Am Heart J; 1994 Jun; 127(6):1504-9. PubMed ID: 8197975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction < or = 40%.
    O'Keefe JH; Allan JJ; McCallister BD; McConahay DR; Vacek JL; Piehler JM; Ligon R; Hartzler GO
    Am J Cardiol; 1993 Apr; 71(11):897-901. PubMed ID: 8465778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative long-term results of coronary angioplasty in single and multivessel disease.
    Henderson RA; Raskino C; Karani S; Sowton E
    Eur Heart J; 1992 Jun; 13(6):781-6. PubMed ID: 1623867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivessel and single-vessel coronary angioplasty: a comparative study.
    Hollman J; Simpfendorfer C; Franco I; Whitlow P; Goormastic M
    Am Heart J; 1992 Jul; 124(1):9-12. PubMed ID: 1615833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immediate and long term results of percutaneous coronary angioplasty in patients aged 70 and over.
    de Jaegere P; de Feyter P; van Domburg R; Suryapranata H; van den Brand M; Serruys PW
    Br Heart J; 1992 Feb; 67(2):138-43. PubMed ID: 1540433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI).
    Hamm CW; Reimers J; Ischinger T; Rupprecht HJ; Berger J; Bleifeld W
    N Engl J Med; 1994 Oct; 331(16):1037-43. PubMed ID: 8090162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silent myocardial ischemia after percutaneous transluminal coronary angioplasty and its prognostic significance.
    Kaul U; Dev V; Manchanda SC; Wasir HS
    Clin Cardiol; 1991 Jul; 14(7):563-6. PubMed ID: 1747965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty.
    Weintraub WS; Ghazzal ZM; Douglas JS; Liberman HA; Morris DC; Cohen CL; King SB
    Circulation; 1993 Mar; 87(3):831-40. PubMed ID: 8443903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry.
    Bell MR; Gersh BJ; Schaff HV; Holmes DR; Fisher LD; Alderman EL; Myers WO; Parsons LS; Reeder GS
    Circulation; 1992 Aug; 86(2):446-57. PubMed ID: 1638714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty.
    Mabin TA; Holmes DR; Smith HC; Vlietstra RE; Reeder GS; Bresnahan JF; Bove AA; Hammes LN; Elveback LR; Orszulak TA
    Circulation; 1985 Apr; 71(4):754-60. PubMed ID: 3156011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute occlusion in multiple lesion coronary angioplasty: frequency and management.
    Gaul G; Hollman J; Simpfendorfer C; Franco I
    J Am Coll Cardiol; 1989 Feb; 13(2):283-8. PubMed ID: 2521500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry.
    Cuculi F; Banning AP; Abizaid A; Bartorelli AL; Baux AC; Dzavík V; Ellis S; Gao R; Holmes D; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Spaulding C; Stoll HP; Worthley S; Urban P;
    EuroIntervention; 2011 Dec; 7(8):962-8. PubMed ID: 22157482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularization.
    Kloeter UC; Jander NG; Buser PT; Osswald S; Mueller-Brand J; Pfisterer ME
    Int J Cardiol; 2001 Jul; 79(2-3):197-205. PubMed ID: 11461742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.
    Kereiakes DJ; Sudhir K; Hermiller JB; Gordon PC; Ferguson J; Yaqub M; Sood P; Su X; Yakubov S; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2010 Dec; 3(12):1229-39. PubMed ID: 21232716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.